Icon Genetics GmbH:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Icon Genetics GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C12327
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Icon Genetics GmbH (Icon Genetics), a subsidiary of Denka Co Ltd, is a technology company that offers plant engineering technologies. The company develops, manufactures and markets biopharmaceutical product candidates, engineered organisms and technology platforms for plant biotechnology and plant-based production. It commercializes proprietary transgene operating systems suites of technologies for nuclear transformation of plants, plastid transformation and pro-viral transfection of plants. The company offers production platforms and product prototypes for various pharmaceutical, animal health and chemical biotech markets. Icon Genetics is headquartered in Halle, Germany.

Icon Genetics GmbH – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Icon Genetics GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Icon Genetics GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Icon Genetics GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Icon Genetics GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Icon Genetics GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Icon Genetics GmbH, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Council for Scientific and Industrial Research Enters Into Partnership with Icon Genetics 10
Merger 11
Kentucky Bioprocessing, Icon Genetics And Mapp Biopharma Plan To Merge 11
Acquisition 12
Denki Kagaku Acquires Icon Genetics from Nomad Bioscience for USD81.6 Million 12
Nomad Bioscience Acquires Icon Genetics From Bayer Innovation 13
Icon Genetics GmbH – Key Competitors 14
Icon Genetics GmbH – Key Employees 15
Icon Genetics GmbH – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Icon Genetics GmbH, Pharmaceuticals & Healthcare, Key Facts 2
Icon Genetics GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Icon Genetics GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Icon Genetics GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Icon Genetics GmbH, Deals By Therapy Area, 2012 to YTD 2018 8
Icon Genetics GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Council for Scientific and Industrial Research Enters Into Partnership with Icon Genetics 10
Kentucky Bioprocessing, Icon Genetics And Mapp Biopharma Plan To Merge 11
Denki Kagaku Acquires Icon Genetics from Nomad Bioscience for USD81.6 Million 12
Nomad Bioscience Acquires Icon Genetics From Bayer Innovation 13
Icon Genetics GmbH, Key Competitors 14
Icon Genetics GmbH, Key Employees 15

List of Figures
Icon Genetics GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Icon Genetics GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Icon Genetics GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Icon Genetics GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Icon Genetics GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Icon Genetics GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Icon Genetics GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Icon Genetics GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Icon Genetics GmbH:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • TissueGen Inc:企業の製品パイプライン分析2018
    Summary TissueGen Inc (TissueGen) is a medical device company that develops fiber for advance drug delivery, nerve regeneration and tissue engineering. The company’s products comprise pharmaceutical fibers, growth factor fibers and stent. It offers pharmaceutical fibers and growth factor fibers. Tis …
  • Harvard Bioscience Inc (HBIO):製薬・医療:M&Aディール及び事業提携情報
    Summary Harvard Bioscience Inc (Harvard Bioscience) develops, manufactures and markets scientific instruments systems and lab consumables. The company’s product portfolio encompasses physiology, cell, molecular instruments products; electrophysiology products; and laboratory products and supplies. I …
  • Regeneron Pharmaceuticals Inc (REGN):製薬・医療:M&Aディール及び事業提携情報
    Summary Regeneron Pharmaceuticals Inc (Regeneron) is a biopharmaceutical company, which discovers, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. The company’s six US FDA-approved medicines and product candidates in development help patients wit …
  • Harvard Bioscience Inc (HBIO):企業の財務・戦略的SWOT分析
    Harvard Bioscience Inc (HBIO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Abbott Vascular Inc-医療機器分野:企業M&A・提携分析
    Summary Abbott Vascular Inc (Abbott Vascular), formerly Perclose, Inc., a subsidiary of Abbott Laboratories, is a medical device company that develops manufactures and markets cardiovascular devices. The company offers coronary intervention, peripheral intervention, and structural heart products. It …
  • Schneider Electric (Australia) Pty Ltd:企業の戦略的SWOT分析
    Schneider Electric (Australia) Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • Sumitomo Corp (8053):電力:M&Aディール及び事業提携情報
    Summary Sumitomo Corp (Sumitomo) is a multifaceted business enterprise. It operates various businesses such as metal products, transportation, construction systems, infrastructure, media, network & lifestyle retail, general products, real estate, financial services, logistics, mineral resources and …
  • Amarantus Bioscience Holdings Inc:企業のM&A・事業提携・投資動向
    Amarantus Bioscience Holdings Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Amarantus Bioscience Holdings Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mer …
  • DLF Limited:企業の戦略・SWOT・財務情報
    DLF Limited - Strategy, SWOT and Corporate Finance Report Summary DLF Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • SK Bioland Co Ltd:企業の戦略・SWOT・財務分析
    SK Bioland Co Ltd - Strategy, SWOT and Corporate Finance Report Summary SK Bioland Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Boule Diagnostics AB (BOUL):医療機器:M&Aディール及び事業提携情報
    Summary Boule Diagnostics AB (Boule) is a medical device company that offers hematology diagnostic solutions. The company provides systems and consumer products for complete blood counts to non-institutional healthcare. It offers products such as blood cell counter and instruments, reagents, calibra …
  • OneMain Holdings Inc:企業の戦略・SWOT・財務分析
    OneMain Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary OneMain Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Exmar NV (EXM):企業の財務・戦略的SWOT分析
    Summary Exmar NV (Exmar) a subsidiary of Compagnie Maritime Belge SA, operates as a shipping and energy supply chain solutions provider. The company's service portfolio includes liquefied natural gas (LNG), offshore, liquid petroleum gas (LPG) and supporting services. Its LNG segment offers floating …
  • Endonovo Therapeutics Inc (ENDV):医療機器:M&Aディール及び事業提携情報
    Summary Endonovo Therapeutics Inc (Endonovo Therapeutics) is a commercial stage development company that offers non-invasive medical devices and equipment. The company’s products include Electroceutical Therapy a FDA-Cleared for the palliative treatment of pain and post-surgical edema and CE Marked …
  • Teachers Insurance and Annuity Association of America (TIAA):企業のM&A・事業提携・投資動向
    Teachers Insurance and Annuity Association of America (TIAA) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Teachers Insurance and Annuity Association of America (TIAA) Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report …
  • Dow Brasil SA:企業の戦略的SWOT分析
    Dow Brasil SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • SomaLogic Inc:企業の製品パイプライン分析
    Summary SomaLogic Inc (SomaLogic) is a life science company that discovers, develops and commercializes life science research tools and clinical diagnostic products. The company’s products include SOMAscan assay and SOMAmer reagents. Its SOMAscan reagents is a proteomic platform that combines the pr …
  • Advanced Biological Laboratories SA:医療機器:M&Aディール及び事業提携情報
    Summary Advanced Biological Laboratories SA (ABL) is a medical data technology company that provides integrated software solutions for personalised medicine. The company offers TherapyEdge, a point of care, decision support software for healthcare professionals; and TherapyEdge Box systems, a web ba …
  • Housing Development & Infrastructure Ltd:企業の戦略・SWOT・財務情報
    Housing Development & Infrastructure Ltd - Strategy, SWOT and Corporate Finance Report Summary Housing Development & Infrastructure Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Sandoz International GmbH:企業の戦略・SWOT・財務分析
    Sandoz International GmbH - Strategy, SWOT and Corporate Finance Report Summary Sandoz International GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆